This inventor holds 4 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Biomics Biotechnologies, Co., Ltd., Jiangsu Hansoh Pharmaceutical Co., Ltd., Jiangsu Jibeier Pharmaceutical Co. Ltd.. Active years: 2016-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2025
Title: Wei Peng: Innovator in Pharmaceutical Compounds
Introduction
Wei Peng is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative compounds aimed at improving drug efficacy and reducing side effects. With a total of 4 patents, his work is recognized for its potential impact on treating various medical conditions.
Latest Patents
One of Wei Peng's latest patents is a humidifier that features a deuterium substituted 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]piperazine compound or its derivatives. This pharmaceutical composition is designed to enhance drug concentration in the bloodstream while minimizing oxidative metabolism. The compound is particularly useful in treating affective disorders, depression, and anxiety, as it can lower the required dosage and reduce toxicity and side effects.
Career Highlights
Wei Peng has worked with prominent companies in the pharmaceutical industry, including Jiangsu Hansoh Pharmaceutical Co., Ltd. and Jiangsu Jibeier Pharmaceutical Co. Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in drug development.
Collaborations
Throughout his career, Wei Peng has collaborated with talented individuals such as Jiong Lan and Piaoyang Sun. These partnerships have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking pharmaceutical solutions.
Conclusion
Wei Peng's contributions to the pharmaceutical field through his innovative compounds and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in drug efficacy and patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile